297 related articles for article (PubMed ID: 19264952)
1. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.
Kuboki S; Sakai N; Tschöp J; Edwards MJ; Lentsch AB; Caldwell CC
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1054-9. PubMed ID: 19264952
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.
Lappas CM; Day YJ; Marshall MA; Engelhard VH; Linden J
J Exp Med; 2006 Nov; 203(12):2639-48. PubMed ID: 17088433
[TBL] [Abstract][Full Text] [Related]
3. Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion.
Caldwell CC; Okaya T; Martignoni A; Husted T; Schuster R; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G969-76. PubMed ID: 16002566
[TBL] [Abstract][Full Text] [Related]
4. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359
[TBL] [Abstract][Full Text] [Related]
5. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
6. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
Arrenberg P; Maricic I; Kumar V
Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
[TBL] [Abstract][Full Text] [Related]
7. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
8. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
Sun R; Tian Z; Kulkarni S; Gao B
J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
[TBL] [Abstract][Full Text] [Related]
9. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
[TBL] [Abstract][Full Text] [Related]
10. Innate immune responses involving natural killer and natural killer T cells promote liver regeneration after partial hepatectomy in mice.
Hosoya S; Ikejima K; Takeda K; Arai K; Ishikawa S; Yamagata H; Aoyama T; Kon K; Yamashina S; Watanabe S
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G293-9. PubMed ID: 23086918
[TBL] [Abstract][Full Text] [Related]
11. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
12. Modulating CD4+ T cell migration in the postischemic liver: hepatic stellate cells as new therapeutic target?
Reifart J; Rentsch M; Mende K; Coletti R; Sobocan M; Thasler WE; Khandoga A
Transplantation; 2015 Jan; 99(1):41-7. PubMed ID: 25360872
[TBL] [Abstract][Full Text] [Related]
13. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major.
Ishikawa H; Hisaeda H; Taniguchi M; Nakayama T; Sakai T; Maekawa Y; Nakano Y; Zhang M; Zhang T; Nishitani M; Takashima M; Himeno K
Int Immunol; 2000 Sep; 12(9):1267-74. PubMed ID: 10967021
[TBL] [Abstract][Full Text] [Related]
14. DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice.
Werner JM; Busl E; Farkas SA; Schlitt HJ; Geissler EK; Hornung M
BMC Immunol; 2011 Apr; 12():26. PubMed ID: 21529347
[TBL] [Abstract][Full Text] [Related]
15. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
18. Complexity and function of natural killer T cells with potential application to hepatic transplant survival.
Ware R; Kumar V
Liver Transpl; 2017 Dec; 23(12):1589-1592. PubMed ID: 28945950
[TBL] [Abstract][Full Text] [Related]
19. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
[TBL] [Abstract][Full Text] [Related]
20. Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function.
Joshi SK; Lang ML
Int Immunopharmacol; 2013 Oct; 17(2):260-6. PubMed ID: 23800654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]